Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives

Author(s):  Trimble John O, Light Bob

Issue:  Nov/Dec 2017 - Volume 21, Number 6
View All Articles in Issue

Page(s):  530-535

Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives Page 1
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives Page 2
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives Page 3
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives Page 4
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives Page 5
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives Page 6

Download in electronic PDF format for $65

Abstract:  Transdermal compositions for hormone replacement are comprised of exogenous hormones that are biochemically similar to those produced endogenously by the ovaries or elsewhere in the body. In this work, estradiol, estriol, and testosterone were loaded in transdermal vehicles, prepared using one of three selected penetration enhancer mixtures: Vehicle 1 (olive oil and oleic acid), Vehicle 2 (isopropyl palmitate and lecithin), and Vehicle 3 (isopropyl myristate and lecithin). The influence of penetration enhancers on transdermal delivery was evaluated using Franz-type diffusion cells and Normal Human 3D Model of Epidermal Tissue. Results showed that drug delivery is affected by the penetration enhancer used in the transdermal composition.

Related Keywords: Bob Light, BS Pharm, hormone replacement therapy, HRT, adverse effects, estradiol, estiol, biest, testosterone, estrogens, transdermal delivery, percutaneous delivery, skin penetration enhancer, skin permeation, olive oil, oleic acid, isopropyl palmitate, lecithin, isopropyl myristate, Franz-type diffusion cell, Normal Human 3D Model of Epidermal Tissue, human dermal models, hydrophile-lipophile balance, HLB, drug solubilizing, drug solubility

Related Categories: EXCIPIENTS, HRT, PEER-REVIEWED

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives
Trimble John O
, Light Bob
Nov/Dec 2017
Pg. 530-535

Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives
Trimble John
, Light Bob
May/Jun 2016
Pg. 250-256

Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

The Science Behind Hormone Replacement Therapy, Part 1
Wepfer Scott T
Nov/Dec 2001
Pg. 462-464

Transdermals: The Skin as Part of a Drug Delivery System
Allen Loyd V Jr
Jul/Aug 2011
Pg. 308-315

Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery
Boddu Sai HS
, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
May/Jun 2014
Pg. 256-261

In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Heustess Allie
, Asbill Scott, Eagerton David, Arnold John
Nov/Dec 2014
Pg. 512-515

Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Deleruyelle Laura J
Nov/Dec 2016
Pg. 447-454

Featured Excipient: Flavor Enhancing Agents
Allen Loyd V Jr
Jan/Feb 2003
Pg. 48-50

A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1
Gillson George R
, Zava David T
Jul/Aug 2003
Pg. 250-256